|
Information For:
|
Revision BulletinRocuronium Bromide
In accordance with section 9.05(c) of the Rules and Procedures of the 2005–2010 Council of Experts, the Monograph Development—Psychiatrics and Psychoactives Expert Committee (MDPP) has revised the Rocuronium Bromide monograph in order to reflect the approved ANDAs as follows:
The Rocuronium Bromide Revision Bulletin text supersedes the currently official monograph and will be incorporated into USP 33-NF 28 Reissue. Should you have any questions, please contact Ravi Ravichandran, Ph.D. (301–816–8330 or . Download the Rocuronium Bromide MonographWhat's New
![]() USP recalled USP 33-NF 28 on Jan. 8, 2010. A reissue product will be available in April 2010.
PF 36(2), March-April 2010: IRAs and Errata (03/01/10) February Revision Bulletins (02/26/10) Protamine Monographs: Notice of Intent to Revise (02/26/10) New Draft Pending Standard for the month of February (02/26/10) PF 36(2), March-April 2010: Highlights (02/22/10) Calculation Tool for the Performance Verification Test (PVT) of Dissolution Assemblies (02/22/10) Performance of Equipment to Test Dissolution of Medications Further Assured (02/09/10) New Official Text (01/29/10) Related Resources |
||||||||||||||||||||||||||||
Copyright © 2010 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||